Dr. Kerri Novak is Clinical Associate Professor of Medicine at the University of Calgary and Deputy Division Head. Her clinical practice focuses on inflammatory bowel disease (IBD) and she developed the first clinic in North America to use bedside intestinal ultrasound (IUS) to objectively evaluate the bowel. Kerri is passionate about expanding the use of IUS given its easy, safe repeatability for monitoring patients, in addition to its low cost and accuracy. She is the current Scientific Chair of the International Bowel Ultrasound Group (IBUS) and is a founding member, currently on the executive board. She leads the Canadian group CAN-IUS and continues to promote the use of IUS in Canada and around the world. She trains gastroenterologists from far and wide in her clinic and looks forward to the end of the COVID pandemic when training can resume. Kerri is the principle investigator for a large, international, multicenter study currently underway, aimed to understand how monitoring is experienced by patients with Crohn’s disease and to develop a reproducible, accurate and externally validated activity score for Crohn’s disease, generously funded by the Helmsley Trust. She has 2 teenage girls and a sweet golden doodle who keep her outside and a husband who kindly encourages her and keeps her well.